You may be worried about getting important treatments for your eye condition – especially if treatment is critical to saving vision. The American Academy of Ophthalmology (AAO) and the American Macular Degeneration Foundation (AMDF) offer advice to help patients navigate the changes in eye care during this coronavirus crisis. We summarize the experts here but … Continued
World Sight Day is an international “day of awareness,” coordinated by the International Agency for the Prevention of Blindness (IAPB). The purpose of World Site Day is to focus attention on the global issue of avoidable blindness and visual impairment. It is held each year on the second Thursday of October. This year, World Sight … Continued
How Macular Degeneration Affects Vision A progressive eye disease, age-related macular degeneration (AMD) may occur in one or both eyes and may advance very slowly or quite rapidly. While the condition can be devastating, ophthalmologists reassure patients that macular degeneration alone will not lead to total blindness. The reason is that both the dry and … Continued
Treatments for Dry Macular Degeneration: An Unmet Need Age-Related Macular Degeneration (AMD) is the leading cause of legal blindness in Americans over 65. There are two distinct types of the disease, both of which result in the deterioration of the macula, the central part of the retina that allows a person to see fine detail. … Continued
Treatments for Dry Macular Degeneration: An Unmet Need Age-Related Macular Degeneration (AMD) is the leading cause of legal blindness in Americans over 65. There are two distinct types of the disease, both of which result in the deterioration of the macula, the central part of the retina that allows a person to see fine detail. … Continued
One of the most significant challenges facing eye and vision researchers is developing an effective treatment for dry age-related macular degeneration (AMD). Although there are now a number of well-regarded FDA-approved drug treatments for wet AMD, the key to effective dry AMD treatment remains elusive, although several potential treatments have emerged in recent years. Current … Continued
Low vision and blindness affect a substantial portion of the older adult population in the United States. Although new research from Johns Hopkins University School of Medicine indicates that the annual number of new cases of blindness and low vision among people aged 45 years and older is estimated to double during the next 30 … Continued
New research from University College London has challenged the traditional images that are used to show the visual symptoms associated with dry age-related macular degeneration (AMD), particularly the image at left from the United States National Eye Institute. The researchers suggest that no one image can describe the condition and that “it may be more … Continued
At the Annual Meeting of the American Academy of Ophthalmology (AAO) in New Orleans, Louisiana, November 11-14, 2017, Dr. John D. Shepherd, Director of the Weigel Williamson Center for Visual Rehabilitation at the University of Nebraska Medical Center, delivered a powerful lecture on older adults, depression, and vision loss. Dr. Shepherd discussed his own experience … Continued
One of the most significant challenges facing eye and vision researchers is developing an effective treatment for dry age-related macular degeneration (AMD). Although there are a number of well-regarded FDA-approved drug treatments for wet AMD, the key to effective dry AMD treatment continues to be elusive. Current treatments for dry AMD include a number of … Continued
